Michael Jos. Campbell - Net Worth and Insider Trading

Michael Jos. Campbell Net Worth

The estimated net worth of Michael Jos. Campbell is at least $3,214 dollars as of 2024-06-25. Michael Jos. Campbell is the COO of INVO Bioscience Inc and owns about 3,788 shares of INVO Bioscience Inc (INVO) stock worth over $3,214. Details can be seen in Michael Jos. Campbell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Jos. Campbell has not made any transactions after 2022-06-01 and currently still holds the listed stock(s).

Transaction Summary of Michael Jos. Campbell

Michael Jos. Campbell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Jos. Campbell owns 1 companies in total, including INVO Bioscience Inc (INVO) .

Click here to see the complete history of Michael Jos. Campbell’s form 4 insider trades.

Insider Ownership Summary of Michael Jos. Campbell

Ticker	Comapny	Transaction Date	Type of Owner
INVO	INVO Bioscience Inc	2022-06-01	director

Michael Jos. Campbell Latest Holdings Summary

Michael Jos. Campbell currently owns a total of 1 stock. Michael Jos. Campbell owns 3,788 shares of INVO Bioscience Inc (INVO) as of June 1, 2022, with a value of $3,214.

Latest Holdings of Michael Jos. Campbell

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
INVO	INVO Bioscience Inc	2022-06-01	3,788	0.85	3,214

Holding Weightings of Michael Jos. Campbell

Michael Jos. Campbell Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Jos. Campbell has made a total of 1 transactions in INVO Bioscience Inc (INVO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in INVO Bioscience Inc is the acquisition of 526 shares on June 1, 2022, which cost Michael Jos. Campbell around $10,000.

Insider Trading History of Michael Jos. Campbell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Jos. Campbell Trading Performance

GuruFocus tracks the stock performance after each of Michael Jos. Campbell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Jos. Campbell is 3.3%. GuruFocus also compares Michael Jos. Campbell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Jos. Campbell within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael Jos. Campbell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael Jos. Campbell

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-13.85
Relative Return to S&P 500(%)	-7.12

Michael Jos. Campbell Ownership Network

Ownership Network List of Michael Jos. Campbell

No Data

Ownership Network Relation of Michael Jos. Campbell

Michael Jos. Campbell Owned Company Details

What does INVO Bioscience Inc do?

Who are the key executives at INVO Bioscience Inc?

Michael Jos. Campbell is the director of INVO Bioscience Inc. Other key executives at INVO Bioscience Inc include Chief Financial Officer Andrea Goren , 10 percent owner Awm Investment Company, Inc. , and director & Medical Director Kevin Doody .

INVO Bioscience Inc (INVO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of INVO Bioscience Inc (INVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of INVO Bioscience Inc (INVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

INVO Bioscience Inc (INVO)'s detailed insider trading history can be found in Insider Trading Tracker table.

INVO Bioscience Inc Insider Transactions

No Available Data

Michael Jos. Campbell Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Jos. Campbell. You might contact Michael Jos. Campbell via mailing address: 61 South Hills Drive, Bedford Nh 03110.

Discussions on Michael Jos. Campbell

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.